PharmaTalkRadio8 Nov 2022

Where and How DCTs Can Truly Enable and Close the Gaps between Research and Care

In this session, panelists from pharma and healthcare share perspectives on innovations in decentralized clinical trial technologies that have and have not worked during and throughout COVID. They also discuss: How we are bringing forth trial options to people on their own terms and getting patient inputCreating flexible systems that don’t increase undue burden on hospitals and sitesWhat hasn’t worked and whyManaging cost and spend Speakers: Sharon Hanlon, Head, Clinical Trial Engagement & Enrolment, Bristol Myers SquibbChristina Brennan, MD, MBA, VP, Clinical Research, Northwell HealthJamie Harper, MHA, CCRP, Director, Site Engagement & Relations, WCG ClinicalRamita Tandon, Chief Clinical Trials Officer, Walgreens Health, Walgreens Boots AllianceSusan Wong, PA, Principal Quality & Compliance Manager, gRED, Genentech

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges

For more information, visit theconferenceforum.org

9 Dec 202438min

CMO Misunderstandings about Clinical Operations and How to Improve

Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical ope...

5 Dec 202433min

How Roche is Maximizing the Impact of Patient Insights in Early Development

For more information, go to theconferenceforum.org

3 Dec 202419min

Designing and Developing Drug Delivery for Lower and Middle-Income Countries

This podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and Abb...

21 Nov 202442min